BioD Enhancing Life Through Birth



BioDFactor™ Viable Tissue Matrix is a cryopreserved injectable allograft derived from the human placental tissues developed for use as a wound covering in the treatment of localized tissue defects or areas of inflammation.

PRODUCT FEATURES

  • Placental tissues are a rich source of collagen, elastin, fibronectin, and growth factors to support tissue repair and regeneration. Additionally, amniotic tissue has anti-adhesive and anti-microbial properties important in the treatment of soft tissue injuries
  • Covers and protects the wound or localized area of inflammation and provides a natural scaffold that facilitates the migration and proliferation of the patient’s own cells to the site of injury.
  • Processed using our patent-pending CryoPrime™ processing technique

CLINICAL APPLICATIONS

  • Tissue voids and defects
  • Localized areas of inflammation

UNSURPASSED SAFETY AND QUALITY

From donor qualification to lot-release testing, BioD is committed to the safety and quality of our products.

Most human tissue products are derived from cadavers and processed by third-party tissue banks. At BioD, we believe the use of live, healthy donors is a better approach to regenerative medicine. BioD’s placental-derived allografts are recovered from live, healthy donors that we pre-screen during pregnancy and choose based on our stringent donor selection criteria. From aseptic recovery of the tissue at childbirth to timely processing of our allografts, our protocols and procedures have been developed to meet or exceed all applicable industry standards for the use of human cellular and tissue-based products. Our operating entities are registered with the FDA and accredited by the American Association of Tissue Banks.

DONOR TESTING

All potential donors are pre-screened during an examination of pre-natal medical records and test results. A comprehensive medical history and behavior risk assessment is obtained from the donor prior to donation incorporating U.S. Public Health Service guidelines. Discussions with the physician and/or the donor mother are conducted to identify circumstances that may lead to the exclusion of the donor or donated tissue.

Our infectious disease screening requirements meet or exceed all FDA requirements.

Call today and ask more about how this can help you. 863-299-4551